Archemix Corp.
Archemix Corp.
http://www.archemix.com/ Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts. Biopharmaceuticals > Research and Development 2009-Jul-23 | miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics 2009-Jul-21 | Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics... 2009-May-06 | Archemix Appoints Ken Bate as President and Chief Executive Officer... ArchemixFor detailed information visit the website, please... Archemix
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
Google Ads
Other links at Biopharmaceuticals > Research and Development
Develops proprietary protein modifications including PEG, glycosylation and vaccines. Overview of technologies, clinical trial pipeline, investor data and careers in Redwood City, California. (Nasdaq: MAXY)
Category:
2. Xencor, Inc.
Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDAâ„? Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
Category:
3. Gemac
Researching diagnostics and drug candidates for the treatment of amyotrophic lateral and multiple sclerosis, as well as autoimmune diseases, including anti-idiotypic antibodies. Includes overview of corporation in Cenon, France.
Category:
Main Category
14
100
31
5
50
7
11
40
166
20
59
76
24
75
110
142
7
8
13
30
66
Join Mailing List
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.
Top 10
Directory Statistics
Links: 1054
Categories: 36
Pagerank Statistics
Yahoo News